Erratum to: Prolonged thrombocytopenia after living donor liver transplantation is a strong prognostic predictor irrespective of splenectomy: The significance of ADAMTS13 and graft function (International Journal of Hematology (2014) 99, (418-428) DOI: 10.1007/s12185-014-1543-9);Prolonged thrombocytopenia after living donor liver transplantation is a strong prognostic predictor irrespective of history of splenectomy: The significance of ADAMTS13 and graft function

International Journal of Hematology

Volumn 99, Issue 4, 2014, Pages 418-428

  Nobuoka, Yu ^a   Wada, Hideo ^a   Mizuno, Shugo ^a   Kishiwada, Masashi ^a   Usui, Masanobu ^a   Sakurai, Hiroyuki ^a   Tabata, Masami ^a   Kobayashi, Toshihiko ^a   Nobori, Tsutomu ^a   Uemoto, Shinji ^b   Isaji, Shuji ^a  

^a MIE UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

ADAMTS13; Living donor liver transplantation; Splenectomy; Thrombocytopenia; von Willebrand factor

Indexed keywords

METALLOPROTEINASE; THROMBOSPONDIN 1; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; ADAM PROTEIN; ADAMTS13 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; DONOR SELECTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; HUMAN; LIVER FUNCTION; LIVER TRANSPLANTATION; LIVING DONOR; LIVING DONOR LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PROGNOSIS; RISK FACTOR; SPLENECTOMY; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; THROMBOCYTE COUNT; THROMBOCYTOPENIA; ADVERSE EFFECTS; BLOOD CLOTTING TEST; LIVER FUNCTION TEST; METABOLISM; MIDDLE AGED; MORTALITY; PANCREAS RESECTION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; TIME;

ADAM PROTEINS; ADULT; AGED; BLOOD COAGULATION TESTS; FEMALE; HUMANS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PANCREATECTOMY; PLATELET COUNT; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PROGNOSIS; RISK FACTORS; SPLENECTOMY; THROMBOCYTOPENIA; TIME FACTORS;

EID: 84899657325     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-014-1614-y     Document Type: Erratum

References (41)

1. Kishi Y, Sugawara Y, Akamatsu N, Kaneko J, Tamura S, Kokudo N, et al. Splenectomy and preemptive interferon therapy for hepatitis C patients after living- donor liver transplantation. Clin Transpl. 2005;19(6):769-72. (Pubitemid 41748730)
2. Marubashi S, Dono K, Miyamoto A, Takeda Y, Nagano H, Umeshita K, et al. Impact of graft size on postoperative thrombocytopenia in living donor liver transplant. Arch Surg. 2007;142(11):1054-8. (Pubitemid 350157041)
3. Yoshizumi T, Taketomi A, Soejima Y, Ikegami T, Uchiyama H, Kayashima H, et al. The beneficial role of simultaneous splenectomy in living donor liver transplantation in patients with small-for-size graft. Transpl Int. 2008;21(9):833-42.
4. Kobayashi T, Wada H, Usui M, Sakurai H, Matsumoto T, Nobori T, et al. Decreased ADAMTS13 levels in patients after living donor liver transplantation. Thromb Res. 2009;124(5):541-5.
5. Soejima K, Mimura N, Hirashima M, Maeda H, Hamamoto T, Nakagaki T, et al. A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease? J Biochem. 2001;130(4):475-80. (Pubitemid 33021590)
6. Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 2001;413(6855):488-94. (Pubitemid 32938741)
7. Zheng X, Chung D, Takayama TK, Majerus EM, Sadler JE, Fujikawa K. Structure of von Willebrand factor-cleaving protease (ADAMTS 13), metalloproteinase involved in thrombotic thrombocytopenic purpura. J Biol Chem. 2001;276(44): 41059-63.
8. Plaimauer B, Zimmermann K, Völkel D, Antoine G, Kerschbaumer R, Jenab P, et al. Cloning, expression and characterization of the von Willebrand factor-cleaving pro- tease (ADAMTS 13). Blood. 2002;100(10):3626-32. (Pubitemid 35303932)
9. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. New Engl J Med. 1998;339(22):1578-84. (Pubitemid 28536132)
10. Tsai HM, Lian EC. Antibody to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998;339(22):1585-94. (Pubitemid 28536133)
11. Uemura M, Fujimura M, Matsumoto M, Ishizashi H, Kato S, Matsuyama T, et al. Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis. Thromb Haemost. 2008;99:1019-29. (Pubitemid 351810483)
12. Hyun J, Kim HK, Kim JE, Lim MG, Jung JS, Park S, et al. Correlation between plasma activity of ADAMTS-13 and coagulopathy, and prognosis in disseminated intravascular coagulation. Thromb Res. 2009;124(1):75-9.
13. McCaughan GW, Herkes R, Powers B, Rickard K, Gallagher ND, Thompson JF, et al. Thrombocytopenia post liver transplantation. Correlations with pre-operative platelet count, blood transfusion requirements, allograft function and outcome. J Hepatol. 1992;16(1-2):16-22. (Pubitemid 23013172)
14. Chatzipetrou MA, Tsaroucha AK, Weppler D, Pappas PA, Kenyon NS, Nery JR, et al. Thrombocytopenia after liver transplantation. Transplantation. 1999;67(5):702-6. (Pubitemid 29161710)
15. Chang FY, Singh N, Gayowski T, Wagener MM, Mietzner SM, Stout JE, et al. Thrombocytopenia in liver transplant recipients: predictors, impact on fungal infections, and role of endogenous thrombopoietin. Transplantation. 2000;69(1):70-5. (Pubitemid 30062611)
16. Ben Hamida C, Lauzet JY, Rézaiguia-Delclaux S, Duvoux C, Cherqui D, Duvaldestin P, et al. Effect of severe thrombocytopenia on patient outcome after liver transplantation. Intensive Care Med. 2003;29(5):756-62. (Pubitemid 36609568)
17. Vanhoutte PM. Platelets, endothelium and blood vessel wall. Experientia. 1988;44(2):105-9. (Pubitemid 18074241)
18. Iu S, Harvey PRC, Makowka L, Petrunka CN, Ilson RG, Strasberg SM. Markers of allograft viability in the rat: relationship between transplant viability and liver function in the isolated perfused liver. Transplantation. 1987;44(4):562-9.
19. Alkozai EM, Nijsten MW, de Jong KP, de Boer MT, Peeters PM, Slooff MJ, et al. Immediate postoperative low platelet count is associated with delayed liver function recovery after partial liver resection. Ann Surg. 2010;251(2):300-6.
20. Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T. FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol. 2005;129(1):93-100. (Pubitemid 40524057)
21. Buss DH, Cashell AW, O'Connor ML, Richards F 2nd, Case LD. Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases. Am J Med. 1994;96(3):247-53. (Pubitemid 24099224)
22. Ichikawa N, Kitano K, Shimodaira S, Ishida F, Ito T, Kajikawa S, et al. Changes in serum thrombopoietin levels after splenectomy. Acta Haematol. 1998;100(3):137-41. (Pubitemid 29000759)
23. Richards EM, Alexander GJ, Calne RY, Baglin TP. Thrombocytopenia following liver transplantation is associated with platelet consumption and thrombin generation. Br J Haematol. 1997;98(2):315-21. (Pubitemid 27345104)
24. Hernandez LA, Grisham MB, Twohig B, Arfors KE, Harlan JM, Granger DN. Role of neutrophils in ischemia-reperfusion induced microvascular injury. Am J Physiol. 1987;253:H699-703.
25. Absher E, Labarrere CA, Carter C, Haag B, Faulk WP. The endothelial heparan sulfate-antithrombin III natural anticoagulant pathway in normal and transplanted human kidneys. Transplantation. 1992;53(4):828-34.
26. Vanhoutte PM. Platelets, endothelium and blood vessel wall. Experientia. 1988;44(2):105-9. (Pubitemid 18074241)
27. Iu S, Harvey PRC, Makowka L, Petrunka CN, Ilson RG, Strasberg SM. Markers of allograft viability in the rat: relationship between transplant viability and liver function in the isolated perfused liver. Transplantation. 1987;44(4):562-9.
28. Claus RA, Bockmeyer CL, Budde U, Kentouche K, Sossdorf M, Hilberg T, et al. Variations in the ratio between von Willebrand factor and its cleaving protease during systemic inflammation and association with severity and prognosis of organ failure. Thromb Haemost. 2009;101(2):239-47.
29. Claus RA, Bockmeyer CL, Sossdorf M, Lösche W. The balance between von-Willebrand factor and its cleaving protease ADAMTS13: biomarker in systemic inflammation and development of organ failure? Curr Mol Med. 2010;10(2):236-48.
30. Ko S, Okano E, Kanehiro H, Matsumoto M, Ishizashi H, Uemura M, et al. Plasma ADAMTS13 activity may predict early adverse events in living donor liver transplantation: observations in 3 cases. Liver Transpl. 2006;12(5):859-69.
31. Pereboom ITA, Adelmeijer J, van Leeuwen Y, Hendriks HGD, Porte RJ, Lisman T. Development of a severe von Willebrand factor/ADAMTS13 dysbalance during orthotopic liver transplantation. Am J Transpl. 2009;9(5):1189-96.
32. Mizuno S, Wada H, Hamada T, Nobuoka Y, Tabata M, Nobori T, et al. Lethal hepatic infarction following plasma exchange in living donor liver transplant patients. Transpl Int. 2011;24(7):e57-8.
33. Hori T, Kaido T, Oike F, Ogura Y, Ogawa K, Yonekawa Y, et al. Thrombotic microangiopathy-like disorder after living-donor liver transplantation: a single-center experience in Japan. World J Gastroenterol. 2011;17(14):1848-57.
34. Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002;347:589-600.
35. Nomura S, Ogami K, Kawamura K, Tsukamoto I, Kudo Y, Kanakura Y, et al. Cellular localization of thrombopoietin mRNA in the liver by in situ hybridization. Exp Hematol. 1997;25:565.
36. Kaushansky K. Thrombopoietin: the primary regulator of megakaryocyte and platelet production. Thromb Haemost. 1995;74:521-5.
37. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood. 1995;86:419-31.
38. Kaushansky K. Determinants of platelet number and regulation of thrombopoiesis. J Clin Invest. 2005;115(12):3339-47.
39. Kuter DJ. The biology of thrombopoietin and thrombopoietin receptor agonists. Int J Hematol. 2013;98:10-23.
40. Li J, Xia Y, Kuter DJ. Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics. Br J Haematol. 1999;106(2):345-56. (Pubitemid 29450656)
41. Fielder PJ, Gurney AL, Stefanich E, Marian M, Moore MW, Carver-Moore K, et al. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood. 1996;87(6):2154-61.